Holen Sie sich die Stockscreener-App
2.58
0.39%
-0.010
Handel nachbörslich:
2.51
-0.07
-2.71%
Finanzdaten der Leap Therapeutics Inc-Aktie (LPTX)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
0.03%
14.82
|
14.82 | 14.83 | 14.66 | 42.73 |
| Operating Income/Loss |
0.03%
-14.82
|
-14.82 | -14.83 | -14.66 | -42.73 |
| Income/Loss From Continuing Operations Before Tax |
10.87%
-13.82
|
-12.46 | -13.70 | -13.39 | -41.86 |
| Income/Loss From Continuing Operations After Tax |
10.87%
-13.82
|
-12.46 | -13.70 | -13.39 | -41.86 |
|
Net Income/Loss
|
10.87%
-13.82
|
-12.46 | -13.70 | -13.39 | -41.86 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
1,125%
27.01
|
2.2047 | 26.99 | 14.71 | 129.34 |
| Diluted Average Shares |
1,125%
27.01
|
2.2047 | 26.99 | 14.71 | 129.34 |
| Basic Earnings Per Share |
155.00%
-0.51
|
-0.20 | -0.51 | -0.91 | -0.32 |
| Diluted Earnings Per Share |
155.00%
-0.51
|
-0.20 | -0.51 | -0.91 | -0.32 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.93%
3.55%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):